AQB

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Jim SimonsRenaissance Technologies $99k114.2k shares TrimQ1 2026 $14k $0.8653 $1.04
Ken GriffinCitadel Advisors $29k34k shares TrimQ1 2026 $2.7k $0.8653 $1.04
Jim SimonsRenaissance Technologies $51.1K AddQ3 2025 $51k -- $1.04
Jim SimonsRenaissance Technologies $-8.9K TrimQ2 2025 $8.9k -- $1.04
Jim SimonsRenaissance Technologies $290 AddQ1 2025 $290 -- $1.04
Jim SimonsRenaissance Technologies $-21.3K TrimQ4 2024 $21k -- $1.04

Trade AQB

About AquaBounty Technologies, Inc.

AquaBounty Technologies, Inc. is a biotechnology firm dedicated to boosting productivity within the commercial fish farming sector across the United States and Canada. The company's research initiatives delve into genetics, genomics, fish health, and nutrition. Its flagship offering is AquAdvantage Salmon, a genetically engineered Atlantic salmon intended for human consumption. Beyond this, AquaBounty also supplies conventional Atlantic salmon, along with salmon eggs, juvenile fish (fry), and various byproducts. Established in 1991, the firm maintains its headquarters in Maynard, Massachusetts. It operated under the name Aqua Bounty Farms, Inc. until its rebranding in June 2004.

CEO: David A. Frank
IPO Date: Jan 11, 2017

Market Data

Open: $0.9725
High: $1.00
Low: $0.945
Volume: 49.2K
52W High: $2.95
52W Low: $0.70

Valuation

Market Cap: $3.9M
Enterprise Value: $7.2M

Financials

Free Cash Flow: $-8.7B
Revenue: $0
Net Income: $-18M
Cash: $501k
Debt: $3.5M

Events

EarningsAug 11